Cjex Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.63 Cr
as on 12-12-2024
- Revenue 144.28%
(FY 2022)
- Profit 99.95%
(FY 2022)
- Ebitda -78.53%
(FY 2022)
- Net Worth -0.01%
(FY 2022)
- Total Assets 3.31%
(FY 2022)
About Cjex Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹9.63 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chetan Joshi, Jayesh Joshi, and Subhash Dave serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC149076
- Company No.
149076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Cjex Biochem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Joshi  | Director | 24-Nov-2021 | Current |
| Jayesh Joshi | Director | 03-Aug-2022 | Current |
| Subhash Dave | Director | 30-Jul-2019 | Current |
Financial Performance of Cjex Biochem.
Cjex Biochem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 144.28% increase. The company also saw a substantial improvement in profitability, with a 99.95% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cjex Biochem?
In 2022, Cjex Biochem had a promoter holding of 98.04% and a public holding of 1.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 29 Oct 2016 | ₹1.82 Cr | Satisfied |
Phoenix Arc Private Limited Creation Date: 20 Jan 2009 | ₹1.00 Cr | Satisfied |
Phoenix Arc Private Limited Creation Date: 17 Dec 2007 | ₹1.75 Cr | Satisfied |
How Many Employees Work at Cjex Biochem?
Unlock and access historical data on people associated with Cjex Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cjex Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cjex Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
